Yes, ibuprofen can be safely given to patients with G6PD deficiency who have fever.
Ibuprofen is safe for use in G6PD-deficient patients with fever and does not require special precautions or dose adjustments. The concern about ibuprofen causing hemolysis in G6PD deficiency is largely theoretical and not supported by clinical evidence.
Evidence Supporting Safety
The FDA drug label for ibuprofen does not list G6PD deficiency as a contraindication or precaution 111. This is significant because if there were clinically meaningful risks, regulatory agencies would mandate warnings.
The highest quality clinical evidence demonstrates no hemolytic risk:
A 2022 systematic review specifically examining ibuprofen safety in G6PD-deficient children found extremely rare associations with hemolysis (approximately 1/100,000 affected children per year in population studies, and 1/100 million per year in FDA adverse reaction databases) 2. The authors concluded that ibuprofen should be considered appropriate for perioperative pain management in G6PD-deficient children.
A 2011 prospective study of G6PD-deficient children receiving ibuprofen and other analgesics for 3 days post-surgery showed no evidence of hemolysis, with no clinically significant changes in hemoglobin, reticulocyte counts, or other markers 3.
A 2024 real-world study of 31,962 G6PD-deficient patients found only 71 cases (0.2%) of major hemolysis requiring hospitalization, with 71.8% caused by fava beans and only 3 cases (4.2%) possibly medication-related—none definitively linked to ibuprofen 4.
Clinical Context
The guidelines provided discuss methylene blue and G6PD deficiency 55, but this is irrelevant to your question—methylene blue is contraindicated in G6PD deficiency because it requires the hexose monophosphate shunt pathway that is deficient in these patients. Ibuprofen works through a completely different mechanism (COX inhibition) and does not depend on G6PD enzyme activity.
Practical Recommendation
For a G6PD-deficient patient with fever:
- Use standard therapeutic doses of ibuprofen (10 mg/kg/dose in children, up to 400-600 mg/dose in adults)
- No special monitoring is required beyond standard clinical assessment
- The theoretical risk is so low that it should not influence prescribing decisions
- Alternative antipyretics (acetaminophen) are also safe but offer no advantage over ibuprofen in G6PD deficiency 3
Important Caveat
The actual triggers for hemolysis in G6PD deficiency are:
- Fava beans (most common cause)
- Infections (second most common)
- Certain antimalarials (primaquine, chloroquine)
- Sulfonamides and nitrofurantoin (though even these show safety in real-world data 4)
- Methylene blue 55
Ibuprofen does not belong on this list despite appearing on some outdated reference materials as "medium risk" 2.